Volker Kraus, PhD
developed coverage concepts for pharmaceutical
companies and medical device industry by the
world’s largest Reinsurer Munich RE.
Studies in chemistry in Erlangen and Munich, focussed on medical toxicology with ensuing promotion. After that he was engaged in research projects of environment by the city of Munich. Transition in 2003 to Munich RE and responsible for risk assessment of chemistry, pharmacology and clinical studies. He worked out expert reports for production of drugs as well as operation of blood banks. He represented Munich RE at regulatory authorities, domestic and foreign, including Food and Drug Administration (FDA) in the U.S.back